Assessment of myocardium at risk with contrast enhanced steady-state free precession cine cardiovascular magnetic resonance compared to single-photon emission computed tomography

Journal of Cardiovascular Magnetic Resonance

Volumn 12, Issue 1, 2010, Pages

  Sörensson, Peder ^a   Heiberg, Einar ^b   Saleh, Nawsad ^a   Bouvier, Frederic ^a   Caidahl, Kenneth ^a   Tornvall, Per ^a   Rydén, Lars ^a   Pernow, John ^a   Arheden, Håkan ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

TECHNETIUM 99M; CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADODIAMIDE; GADOLINIUM PENTETATE;

ADULT; ARTICLE; CINE CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; HEART INFARCTION; HEART MUSCLE; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; AGED; ANGIOCARDIOGRAPHY; COMPARATIVE STUDY; MIDDLE AGED; OBSERVER VARIATION; PATHOLOGY; PREDICTION AND FORECASTING; REPRODUCIBILITY; SCINTISCANNING; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; CORONARY OCCLUSION; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME;

EID: 77955865520     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-12-25     Document Type: Article

References (33)

1. Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival. Should the paradigm be expanded? E Braunwald, Circulation 1989 79 441 444 2914356
2. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Lancet 1994 343 311 322 7905143
3. Cardiac protection during acute myocardial infarction: where do we stand in 2004? RA Kloner SH Rezkalla, J Am Coll Cardiol 2004 44 276 286 10.1016/j.jacc.2004.03.068 15261919
4. -2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. EM Antman M Hand PW Armstrong ER Bates LA Green LK Halasyamani JS Hochman HM Krumholz GA Lamas CJ Mullany DL Pearle MA Sloan SC Smith Jr DT Anbe FG Kushner JP Ornato DL Pearle MA Sloan AK Jacobs CD Adams JL Anderson CE Buller MA Creager SM Ettinger JL Halperin SA Hunt BW Lytle R Nishimura RL Page B Riegel LG Tarkington CW Yancy, J Am Coll Cardiol 2008 51 210 247 10.1016/j.jacc.2007.10.001 18191746
5. The "wavefront phenomenon" of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. KA Reimer RB Jennings, Lab Invest 1979 40 633 644 449273
6. Pharmacological possibilities for protection against myocardial reperfusion injury. QD Wang J Pernow PO Sjoquist L Ryden, Cardiovasc Res 2002 55 25 37 10.1016/S0008-6363(02)00261-4 12062706
7. Feasibility of tomographic 99 mTc-hexakis-2-methoxy-2-methylpropyl- isonitrile imaging for the assessment of myocardial area at risk and the effect of treatment in acute myocardial infarction. RJ Gibbons MS Verani T Behrenbeck PA Pellikka MK O'Connor JJ Mahmarian JH Chesebro FJ Wackers, Circulation 1989 80 1277 1286 2530004
8. Area-at-risk determination by technetium-99 m-hexakis-2-methoxyisobutyl isonitrile in experimental reperfused myocardial infarction. PM De Coster W Wijns F Cauwe A Robert C Beckers JA Melin, Circulation 1990 82 2152 2162 2242539
9. Quantification of area at risk during coronary occlusion and degree of myocardial salvage after reperfusion with technetium-99 m methoxyisobutyl isonitrile. AJ Sinusas KA Trautman JD Bergin DD Watson M Ruiz WH Smith GA Beller, Circulation 1990 82 1424 1437 2401074
10. The quantification of infarct size. RJ Gibbons US Valeti PA Araoz AS Jaffe, J Am Coll Cardiol 2004 44 1533 1542 10.1016/j.jacc.2004.06.071 15489082
11. Magnetic resonance imaging as a potential gold standard for infarct quantification. M Carlsson H Arheden CB Higgins M Saeed, J Electrocardiol 2008 41 614 620 10.1016/j.jelectrocard.2008.06.010 18817927
12. Value of contrast-enhanced, balanced cine-MR sequences in the assessment of apparent infarct size after acute myocardial infarction: a prospective comparison with delayed-enhancement sequences. JP Laissy F Hyafil V Huart JM Serfaty S Chillon E Schouman-Claeys M Faraggi, J Magn Reson Imaging 2005 22 765 771 10.1002/jmri.20443 16270294
13. Retrospective determination of the area at risk for reperfused acute myocardial infarction with T2-weighted cardiac magnetic resonance imaging: histopathological and displacement encoding with stimulated echoes (DENSE) functional validations. AH Aletras GS Tilak A Natanzon LY Hsu FM Gonzalez RF Hoyt Jr AE Arai, Circulation 2006 113 1865 1870 10.1161/CIRCULATIONAHA.105. 576025 16606793
14. In vivo T2-weighted magnetic resonance imaging can accurately determine the ischemic area at risk for 2-day-old nonreperfused myocardial infarction. GS Tilak LY Hsu RF Hoyt Jr AE Arai AH Aletras, Invest Radiol 2008 43 7 15 10.1097/RLI.0b013e3181558822 18097272
15. ACUT2E TSE-SSFP: a hybrid method for T2-weighted imaging of edema in the heart. AH Aletras P Kellman JA Derbyshire AE Arai, Magn Reson Med 2008 59 229 235 10.1002/mrm.21490 18228588
16. Delayed enhancement and T2-weighted cardiovascular magnetic resonance imaging differentiate acute from chronic myocardial infarction. H Abdel-Aty A Zagrosek J Schulz-Menger AJ Taylor D Messroghli A Kumar M Gross R Dietz MG Friedrich, Circulation 2004 109 2411 2416 10.1161/01.CIR.0000127428.10985.C6 15123531
17. T2-prepared SSFP improves diagnostic confidence in edema imaging in acute myocardial infarction compared to turbo spin echo. P Kellman AH Aletras C Mancini ER McVeigh AE Arai, Magn Reson Med 2007 57 891 897 10.1002/mrm.21215 17457880
18. The salvaged area at risk in reperfused acute myocardial infarction as visualized by cardiovascular magnetic resonance. MG Friedrich H Abdel-Aty A Taylor J Schulz-Menger D Messroghli R Dietz, J Am Coll Cardiol 2008 51 1581 1587 10.1016/j.jacc.2008.01.019 18420102
19. Reperfusion hemorrhage following acute myocardial infarction: assessment with T2* mapping and effect on measuring the area at risk. DP O'Regan R Ahmed N Karunanithy C Neuwirth Y Tan G Durighel JV Hajnal I Nadra SJ Corbett SA Cook, Radiology 2009 250 916 922 10.1148/radiol.2503081154 19164125
20. Myocardium at risk after acute infarction in humans on cardiac magnetic resonance: quantitative assessment during follow-up and validation with single-photon emission computed tomography. M Carlsson JF Ubachs E Hedstrom E Heiberg S Jovinge H Arheden, JACC Cardiovasc Imaging 2009 2 569 576 10.1016/j.jcmg.2008.11.018 19442942
21. Recent myocardial infarction: assessment with unenhanced T1-weighted MR imaging. JW Goldfarb S Arnold J Han, Radiology 2007 245 245 250 10.1148/radiol.2451061590 17885192
22. Angiographic estimates of myocardium at risk during acute myocardial infarction: validation study using cardiac magnetic resonance imaging. JT Ortiz-Perez SN Meyers DC Lee P Kansal FJ Klocke TA Holly CJ Davidson RO Bonow E Wu, Eur Heart J 2007 28 1750 1758 10.1093/eurheartj/ehm212 17586811
23. Single-shot steady-state free precession can detect myocardial edema in patients: a feasibility study. JD Green JR Clarke JA Flewitt MG Friedrich, J Magn Reson Imaging 2009 30 690 695 10.1002/jmri.21868 19634173
24. Society for Cardiovascular Magnetic Resonance Board of Trustees Task Force on Standardized Protocols: Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols. CM Kramer J Barkhausen SD Flamm RJ Kim E Nagel, J Cardiovasc Magn Reson 2008 10 35 10.1186/1532-429X-10-35 18605997
25. Rapid initial reduction of hyperenhanced myocardium after reperfused first myocardial infarction suggests recovery of the peri-infarction zone: one-year follow-up by MRI. H Engblom E Hedstrom E Heiberg GS Wagner O Pahlm H Arheden, Circ Cardiovasc Imaging 2009 2 47 55 10.1161/CIRCIMAGING.108.802199 19808564
26. Design and Validation of Segment - a Freely Available Software for Cardiovascular Image Analysis. E Heiberg J Sjögren M Ugander M Carlsson H Engblom H Arheden, BMC Medical Imaging 2010 10 1 10.1186/1471-2342-10-1 20064248
27. Automatic quantification of myocardial perfusion SPECT defects in patients with acute coronary occlusion. H Soneson H Engblom H Arheden E Heiberg, Journal of Nuclear Cardiology 2010 20440591
28. An Improved Method for Automatic Segmentation of the Left Ventricle in Myocardial Perfusion SPECT. H Soneson JF Ubachs M Ugander H Arheden E Heiberg, J Nucl Med 2009 50 205 213 10.2967/jnumed.108.057323 19164235
29. A novel method for quantifying myocardial perfusion SPECT defect size by co-registration and fusion with MRI - an experimental ex vivo imaging pig heart study. M Ugander H Soneson E Heiberg H Engblom Jvd Pals D Erlinge H Arheden, X Cardiovascular Spring Meeting. Malmö 2008
30. Automated quantification of myocardial infarction from MR images by accounting for partial volume effects: animal, phantom, and human study. E Heiberg M Ugander H Engblom M Gotberg GK Olivecrona D Erlinge H Arheden, Radiology 2008 246 581 588 10.1148/radiol.2461062164 18055873
31. Acute oedema in the evaluation of microvascular reperfusion and myocardial salvage in reperfused myocardial infarction with cardiac magnetic resonance imaging. A Phrommintikul H Abdel-Aty J Schulz-Menger MG Friedrich AJ Taylor, Eur J Radiol 2009 19375879
32. Strategies for increasing the sensitivity of gadolinium based MRI contrast agents. P Caravan, Chem Soc Rev 2006 35 512 523 10.1039/b510982p 16729145
33. Therapy-dependent influence of time-to-treatment interval on myocardial salvage in patients with acute myocardial infarction treated with coronary artery stenting or thrombolysis. A Schomig G Ndrepepa J Mehilli M Schwaiger H Schuhlen S Nekolla J Pache S Martinoff H Bollwein A Kastrati, Circulation 2003 108 1084 1088 10.1161/01.CIR.0000086346.32856.9C 12925458